These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37812916)

  • 41. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer.
    Kishi N; Matsuo Y; Menju T; Hamaji M; Nakakura A; Hanazawa H; Takehana K; Date H; Mizowaki T
    J Radiat Res; 2022 Sep; 63(5):758-771. PubMed ID: 35818291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
    Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
    Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
    Wang L; Ge L; You S; Liu Y; Ren Y
    J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcomes of left upper segmentectomy vs. lobectomy for early non-small-cell lung cancer: a nationwide database study in Japan.
    Tane S; Okami J; Maniwa Y; Shintani Y; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
    Surg Today; 2024 Oct; 54(10):1162-1172. PubMed ID: 38635057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis.
    Yendamuri S; Sharma R; Demmy M; Groman A; Hennon M; Dexter E; Nwogu C; Miller A; Demmy T
    J Surg Res; 2013 Jul; 183(1):27-32. PubMed ID: 23260233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 48. Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database.
    Paul S; Isaacs AJ; Treasure T; Altorki NK; Sedrakyan A
    BMJ; 2014 Oct; 349():g5575. PubMed ID: 25277994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC.
    Dalwadi SM; Savjani RR; Bernicker EH; Butler EB; Teh BS; Farach AM
    Am J Clin Oncol; 2019 Nov; 42(11):851-855. PubMed ID: 31573986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of metastatic lymph nodes ratio in overall survival for patients with resected nonsmall cell lung cancer: a retrospective cohort study.
    Lin X; Yao J; Huang B; Chen T; Xie L; Huang R
    Eur J Cancer Prev; 2024 Jul; 33(4):376-385. PubMed ID: 38842873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.
    Wu LL; Lai JJ; Liu X; Huang YY; Lin P; Long H; Zhang LJ; Ma GW
    World J Surg Oncol; 2020 Dec; 18(1):322. PubMed ID: 33287841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection.
    Veluswamy RR; Mhango G; Bonomi M; Neugut AI; Hershman DL; Aldridge MD; Wisnivesky JP
    Ann Am Thorac Soc; 2013 Dec; 10(6):622-8. PubMed ID: 24024700
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncological Outcomes of Sub-Lobar Resection Versus Lobectomy for Stage I Non-Small Cell Lung Cancer.
    Fatima M; Sehar A; Zaheer Z; Khan MH; Rehman OU; Abid SF; Ahmad U; Bajwa A; Cheema HA; Maqsood HA; Martins RS; Naqi SA
    J Surg Res; 2024 Oct; 302():302-316. PubMed ID: 39121798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
    Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A propensity score matching analysis of survival following segmentectomy or wedge resection in early-stage lung invasive adenocarcinoma or squamous cell carcinoma.
    Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Mar; 7(12):13880-5. PubMed ID: 26871600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
    Hao Z; Liang H; Zhang Y; Wei W; Lan Y; Qiu S; Lin G; Wang R; Liu Y; Chen Y; Huang J; Wang W; Cui F; Goto T; Jeong JY; Veronesi G; Lopez-Pastorini A; Igai H; Liang W; He J; Liu J
    Transl Lung Cancer Res; 2021 Mar; 10(3):1408-1423. PubMed ID: 33889519
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
    Gao L; Shen L; Wang K; Lu S
    Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Aug; 3(8):880-6. PubMed ID: 18670306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.